60 DEGREES PHARMACEUTICALS, INC.: cost_of_revenue
| Value | {"amount": 384765, "concept": "us-gaap:CostOfRevenue", "currency": "USD"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | 60 DEGREES PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:51.297335+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9480d0be-6b7d-47b6-9284-c325ab38c175
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001013762-25-003343Retrieved: 2026-08-19T18:58:51.297335+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946563/cost-of-revenue/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9480d0be-6b7d-47b6-9284-c325ab38c175
History
- no predecessors — first report